Malignant Vaginal Neoplasm — Trials

Malignant Vaginal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

127 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 31
Recruiting: 20
Ph III recruiting: 2
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.3%
Trials / 1,000 deaths: 70.8 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04895020	Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years	unknown	Phase 3	1,200	Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY	1	Apr 17, 2024	clinicaltrials
NCT01087268	Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer	unknown	Phase 3	75	Royal Marsden NHS Foundation TrustOTHER	1	Jul 15, 2011